| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |